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Abstract
Smokers are more susceptible to respiratory infections, including influenza. To explore the effect
of smoking on influenza-induced responses within the nasal mucosa, we have developed a
protocol using inoculation with live attenuated influenza virus (LAIV) vaccine followed by
sampling of the nasal mucosa. Mucosal cell populations were harvested through superficial biopsy
of the nasal inferior turbinate pre and post LAIV inoculation and analyzed using flow cytometry.
The majority of nasal biopsy CD45+ immune cells at baseline were CD3+ T lymphocytes.
Following LAIV, these lymphocytes increased in nonsmokers but not in smokers. A subset of
individuals was negative for helper T cell marker CD4 and cytotoxic T cell marker CD8 but
positive for the γδ T cell receptor (TCR). Increases in γδ TCR+ cells were greater in nonsmokers,
than in smokers. Thus, LAIV-induced changes in CD3 T as well as γδ T lymphocyte percentages
are suppressed in smokers compared to nonsmokers.
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Introduction
Environmental stimuli, such as inhaled pollutants and pathogens, can initiate immune
responses in the nasal mucosa that impact overall respiratory health. Cigarette smoke in
particular is a risk factor for respiratory infections including influenza virus. Despite a clear
epidemiological link, the mechanisms underlying this susceptibility are unknown. Although
deficiencies in innate immune nasal defenses have been suggested [1–3], the effects of
smoking on adaptive lymphocyte responses are not well understood. During influenza
infection, the activation of the adaptive immune system, including T and B lymphocytes, is
necessary to clear the initial infection through antibody and cell mediated cytolysis of virus
infected cells, and to generate a memory response. The adaptive T cell response culminates
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in the formation of specific memory T and B cells that patrol the circulation to mount an
immediate adaptive immune response upon subsequent encounters with the same antigen.
While there do not appear to be differences in influenza-specific antibody production in
smokers [4–6], the effect of smoking status on the ability of T cells to mount proper mucosal
and memory immune responses is unknown. We have shown previously that cigarette
smoke exposure to nasal epithelial cells decreases their ability to activate dendritic cells
(DC) during influenza infection. Because T cell activity is influenced by DC activation, we
hypothesized that smokers have decreased T cell activation following influenza infection
compared to nonsmokers.
We have previously used live attenuated influenza virus (LAIV), an influenza vaccine that
induces immune responses to generate viral memory without causing actual disease [7–9], to
demonstrate that smokers have markers of increased viral replication in nasal washes
following inoculation [3]. LAIV generates secretion of lymphokines, including IP-10, within
the nasal passages that are suppressed in smokers [3]. These lymphokines are important in
attracting lymphocytes, such as natural killer (NK) cells and T lymphocytes to the nasal
airways following viral infection. While animal models have shown that virus specific CD8
T cells migrate to the lower airways by day 7 post LAIV [10] the effects of LAIV on human
nasal tissue itself with regards to the T cell trafficking are unknown. To assess the effects of
cigarette smoking on LAIV-induced lymphocyte activation within the nasal mucosa, we
administered LAIV to healthy young individuals as described previously [3] and quantified
immune cells in superficial nasal biopsies using flow cytometry.
2. Materials and Methods
Study Design
This was a prospective longitudinal study characterizing responses to LAIV in between
cohorts of healthy young adult smokers and nonsmokers. Subjects were inoculated with the
2009–2010 LAIV strain. The study design was as described before [3,16]. Baseline
measurements were done at a screening visit, approximately 2–3 weeks prior to inoculation
with LAIV. On Day 0 subjects received a standard nasal inoculum of LAIV (FluMist®,
MedImmune, Gaithersburg, MD; administered by study nurse according to manufacturer's
instructions) in both nostrils, then returned on day 1 post-LAIV for nasal biopsy in the left
nostril and day 4 post-LAIV for nasal biopsy in the right nostril. Serial nasal lavages were
obtained on Days 0–4 and Day 9 post LAIV to assay for T cell populations.
Study Subject Description
Subjects were identified as described before [3] and included healthy young adults between
18–35. Nonsmokers (n=11) were 7 males and 4 females with an average age of 21.5±0.8 and
an average BMI of 25.5±1.9. Smokers (n=12) were 10 males and 2 females with an average
age of 25.3±1.3 and an average BMI of 24.8±1.7. . Subject exposure history questionnaires
were used to estimate cigarette smoke exposure. Smokers smoked an average of 11.2±1.6
cigarettes per day with nonsmokers reporting no cigarette use. Urine cotinine was measured
by ELISA (Bio-Quant, Inc., San Diego, CA) and expressed as a ratio to creatinine, measured
by a colorimetric assay (Oxford Biomedical Research, Rochester Hills, MI). Ratio of urine
cotinine to creatine was 55.2±8.0 in smokers and 0.0±0.0 in nonsmokers. Exclusion criteria
were as described before [3]. No serious adverse events occurred among subjects completing
the protocol. Informed consent was obtained from all subjects and the protocol was
approved by the UNC Biomedical Institutional Review Board.
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Nasal biopsies were harvested from the inferior turbinates of both nostrils using a
RhinoProbe cuvette and were placed in RPMI media. Biopsies were pelleted and treated
with 15µg/ml DNAse-1 (Roche, Indianapolis, IN) and 5µg/ml pronase (Sigma, St. Louis,
MO) for 30 minutes. FBS (Invitrogen) at a final concentration of 10% was added to the cell
pellet and filtered with a 40 uM cell strainer (BD Falcon, San Jose, CA) to remove larger
epithelial cells. The cell pellet was resuspended in 100 µl of flow cytometry buffer (PBS
plus 1% heat inactivated FBS plus 0.09% sodium azide) and stained with surface markers
CD45 APC-cy7, CD3 PerCP, CD4 APC, CD8 PE, CD69 APC (BDBiosciences), and pan γδ
TCR FITC (Biolegend, San Diego, CA) for 20 minutes at room temperature. Cells were
washed with flow buffer, fixed with 0.5% paraformaldehyde, and analyzed on a BDLSRII
flow cytometer within 24 hours. T cells were identified by gating using forward scatter
(FSC) and side scatter (SSC) settings and gating on cells staining positive for CD45 and
CD3.
Statistical Analysis
The effects of LAIV on nasal biopsy responses were analyzed using a Wilcoxon signed rank
test. Intergroup differences were determined using a Mann Whitney Test. Data were shown
as mean ± SEM.
3. Results
T cells Are Present In Nasal Biopsies At Baseline
Nasal biopsies were harvested at screen day and processed for flow cytometry. The majority
of nasal biopsy cells were epithelial cells, characterized by high forward scatter fluorescence
and high side scatter fluorescence (Figure 1A). A population of epithelial cells in gate P2
had high nonspecific staining for immune markers that did not exceed isotype matched
controls (data not shown). A distinct population of immune cells was identified based on
high CD45 staining and low side scatter fluorescence in gate P1 as shown in Figure 1B.
CD45+ cells were positive for T cell marker CD3 (Figure 1C) but were negative for
activated lymphocyte marker CD69 (Figure 1D), helper T cell marker CD4 (Figure 1E), and
cytotoxic T cell marker CD8 (Figure 1F). CD3 T cells were not identified in nasal lavage
populations following LAIV (data not shown for this sample set, see previous analysis of
nasal lavage cell populations following LAIV in nonsmokers and smokers) [16].
LAIV Inoculation Modifies T Cell Populations in Nasal Biopsies
Pre- and Day 4 post-LAIV nasal biopsies were collected from nonsmokers and smokers and
processed for flow cytometry. CD3+CD45+CD4-CD8- T cells as percent of total nasal
biopsy cells increased in nonsmokers (P = 0.008, Wilcoxon signed rank test) but not
smokers (P = 0.300) (Figure 1G). These CD3 T cells were neither helper (CD4) nor
cytotoxic (CD8) T cells. To identify these non-classical T cells, pan γδ T cell receptor
(TCR) expression was evaluated. Only the subset of individuals with both pre and post
LAIV γδ TCR expression data (N=5, nonsmokers and N=8 smokers) were included in the
analysis. A representative flow cytometric histogram details the γδ TCR expression relative
to isotype control (Figure 2A). Similar to the pattern for CD3+ T cells, delta change in γδ T
cell percentages (Figure 2B) was suppressed in smokers compared to nonsmokers (P =
0.045) within the sample subset..
4. Discussion
In superficial nasal mucosal biopsies in human volunteers, we have identified a cell
population with characteristics of γδ T cells which appears to increase several days
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following LAIV inoculation. This is a novel finding and is the first evidence that γδ T cells
may participate in early influenza-induced mucosal responses in humans. γδ T lymphocytes
or intraepithelial lymphocytes are at their highest concentration in epithelial tissues and have
been identified in bronchial biopsies in individuals at baseline [11]. Their location in
mucosal epithelia allows them to quickly respond to virus infections, and γδ T cells sense
“danger” from nearby epithelial cells through recognition of stressed cell ligands that are
upregulated by viral infections [12] and from activation by virus-induced proinflammatory
cytokines in the epithelial microenvironment [13]. γδ T cells migrate to the lung following
influenza infection in response to chemokines [14, 15], which supports the LAIV-induced
responses observed here. During an influenza infection, γδ T cells could kill virus infected
epithelial cells similar to cytotoxic T and NK cells [13] and also could produce cytokines
such as IFNγ, IL-17, and MCP-1 to induce immune cell chemotaxis [13]. We have
previously shown both that cytotoxic NK cell activity [16] as well as IFNγ levels [3] are
suppressed in smokers following LAIV inoculation. Therefore, because γδ T cells and NK
cells share functional redundancy, deficiencies in γδ T cell as well as NK cell activity could
contribute to the suppression of LAIV-induced IFNγ secretion observed in smokers. One
limitation of our study was the small sample subset available for analysis of γδ TCR
expression. Initial studies were designed to follow classical CD4 and CD8 T cells before and
after LAIV inoculation. However, our results revealed a non-classical CD3 T cell population
that necessitated altering our protocol to include analysis of γδ T cells. Limitations arising
from the small subset used to assess γδ T cell populations within this study could be
addressed by a larger more definitive study that fully explores γδ T cell activation markers,
specific TCR subsets, and γδ T cell-secreted cytokines.
We did not observe significant populations of CD4 or CD8 T cells in the nasal mucosa at
baseline. This is in contrast to another report that identifies CD8+ α/β T cells as the main
phenotype of intraepithelial nasal mucosal T cells [17]. However, subjects in that cohort
underwent nasal surgery to obtain tissue samples whereas the subjects here underwent
superficial nasal scrapes. It is likely the depth of the biopsy impacts the phenotype of
intraepithelial lymphocytes recovered. We also did not observe increases in conventional T
cell percentages by day 4 post LAIV. This is likely because influenza specific lymphocytes
such as CD8 T cells do not migrate to the airways until day 7 post infection [18]. Our
protocol was designed to characterize early host defense processes after virus inoculation,
but modifying our LAIV protocol to include later time points may capture influx of
influenza specific CD4 or CD8 T cells.
There are conflicting data exploring the effects of smoking on respiratory mucosal T cell
function in humans. Several groups have indicated that both smokers and smokers with
COPD had increased CD3+CD8+ T cell percentages in bronchial biopsies [19] as well as
lung parenchyma [20] at baseline compared to never smokers. However, other researchers
have demonstrated that sputum CD8+ T lymphocytes are decreased in smokers before
smoking cessation compared to after cessation and never smokers [21]. In addition, these
CD8+ T cells were different compared to the γδ T cell population described in this study,
although increased γδ T cell percentages have been identified in the BAL of smokers [22].
In addition, smokers with normal lung function had increased expression of CD4+CD25+
regulatory T cells within the BAL compared to never-smokers [23]. Therefore, while it is
likely that smokers exhibit constitutive inflammation in the lower airways characterized by
cytotoxic T cell infiltration, it is unclear what effect smoking may have on cytotoxic T cells
in the nasal mucosa.
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Cigarette smoking may inhibit virus-induced responses of γδ T cells following inoculation
with LAIV. Understanding the role of cigarette smoke-induced suppression of γδ T cells in
the context of immune responses within the nasal mucosa could provide novel therapeutic
targets. In addition, the in vivo T cell assays used to identify and characterize a relatively
rare intra-mucosal immune cell type from human biopsy samples, which can be obtained
through non-invasive procedures as shown here, could prove a useful technique to examine
immunotoxicological responses of other inhaled agents.
Highlights
We have identified γδ T cells infiltrating into the nasal mucosa in response to LAIV.
We show that infiltration of γδ T cells is suppressed in smokers.
Flow cytometry of can be used to characterize nasal mucosal immune cell phenotypes.
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CD45+CD3+ Lymphocyte Populations in Nonsmokers and Smokers At Baseline and
Following LAIV. Nasal biopsies obtained on screen day were processed and stained with
immune markers for flow cytometric analysis. A) Forward scatter (FSC) and side scatter
(SSC) fluorescence. B) Nasal leukocytes were identified based on SSC voltages and positive
staining for CD45 in gate P1. Expression of immune markers on CD45+ cells for C) CD3,
D) CD69, E) CD4, and F) CD8. G) CD3+CD4−CD8− T lymphocyte responses are
determined by subtracting pre LAIV (baseline) percentages from post LAIV T cell
percentages. * P < 0.05 (Mann Whitney test) Open histograms = isotype controls, black
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histograms = surface marker staining. A representative image of flow cytometric staining in
normal individuals at baseline is shown.
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γδ TCR Expression on Nasal Lymphocytes. CD45+CD3+ lymphocytes were evaluated for
γδ TCR expression in a subset of individuals. A) A representative image shows istoype
control staining (open histogram) and γδ TCR staining (black histogram) on
CD45+CD3+CD4−CD8− lymphocytes. B) γδ T lymphocyte responses are determined by
subtracting pre LAIV (baseline) percentages from post LAIV percentages for
CD3+CD4−CD8− T cells. * P <0.05 (Mann Whitney test).
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